Harrow Health Reports Q3 Earnings Beat with $99.3 Million Revenue
Harrow Health (HROW) reported third-quarter financial results that exceeded analyst expectations for both earnings and revenue. The company posted a GAAP EPS of $0.25, surpassing estimates by $0.06, while total revenue reached $99.3 million, representing a 38.7% increase year-over-year. The company achieved a significant turnaround in profitability, reporting a GAAP net income of $9.8 million for the quarter. This is a substantial improvement compared to the $17.3 million net loss reported in the second quarter. The positive bottom line was bolstered by a one-time litigation settlement gain of $5.0 million.
Tickers: $HROW
Topics: earnings beat litigation settlement net income revenue growth
Read the full article at Seeking Alpha
Part of the story Clover Health GAAP EPS of $0.01 beats by $0.01, revenue of $759.3M beats by $20.88M (6 articles)